Connect with us

National

41,831 Fresh Coronavirus Cases In India, Marginally Higher Than Yesterday – dot newz

Published

on


New Delhi:
India has recorded 41,831 lakh fresh cases – marginally higher than yesterday – and 541 deaths in the last 24 hours. So far, 4.24 lakh people have died of Covid in the country while the total caseload stands at 3.16 crore.

Here are the top 10 updates on coronavirus

  1. India’s ‘R-Value’ is inching up, and it’s a cause of concern, AIIMS Chief Dr Randeep Guleria said on Saturday, stressing on the need of aggressive containment strategies in the parts of the country that are witnessing a surge in fresh Covid infections.

  2. The government has stressed on the need of strict restrictions in districts witnessing a positivity rate of more than 10 per cent.

  3. Ten states – Kerala, Maharashtra, Karnataka, Tamil Nadu, Odisha, Assam, Mizoram, Meghalaya, Andhra Pradesh and Manipur – are either witnessing a surge in new Covid cases or a rise in positivity rate.

  4. Easing of lockdown combined with pandemic fatigue, lack of community adherence to Covid-appropriate behavior, and circulation of more transmissible variants of SARS-CoV-2 can be attributed to the surge in new cases in some states and union territories, the government had said earlier.

  5. The Delhi government has, meanwhile, directed private hospitals to discontinue their extended Covid facilities at hotels with immediate effect in view of the marked improvement in the coronavirus situation in the capital.

  6. During the second wave, hotels in the national capital were linked with private hospitals in order to convert them into extended Covid facilities due to the rising number of coronavirus cases. Delhi had faced a brutal second Covid wave with shortage of beds and oxygen.

  7. Karnataka on Saturday revised its Covid guidelines to make a negative RTPCR result not older than 72 hours mandatory for those entering the state from neighbouring Kerala and Maharashtra. This is irrespective of the visitors’ vaccination status.

  8. The government has reminded the states and Union territories to prioritise vaccination of vagabonds and destitute in the Nationwide COVID-19 Vaccination Drive.

  9. The World Health Oraganistation has urged the world to quickly contain the virus mutation before it turns into something deadlier and draws out the pandemic amid the mushrooming outbreaks of the highly contagious Delta variant in China and Australia.

  10. Worldwide, coronavirus infections are once again on the upswing, with the WHO announcing an 80 percent average increase over the past four weeks in five of the health agency’s six regions



Source link

National

Amarinder Singh On Backfoot? Congress Calls Key Meeting Of Punjab MLAs – dot newz

Published

on

By


The 117-member Punjab assembly will vote early next year (File)

New Delhi:

There is fresh sparking in the Punjab unit of the Congress. Citing “representation from a large number of MLAs”, the Congress, in a late night tweet, has called for a key meeting of its Punjab legislators today.

“The AICC has received a representation from a large number of MLAs from the Congress party, requesting to immediately convene a meeting of the Congress Legislature Party (CLP) of Punjab. Accordingly, a meeting of the CLP has been convened at 5 PM on September 18 at Punjab Pradesh Congress Committee office.

“AICC directs the PPCC to facilitate this meeting. All congress MLAs of Punjab are requested to kindly attend this meeting,” Harish Rawat, Congress’s Punjab in-charge, tweeted Friday night.

Mr Rawat also tagged Congress leader Rahul Gandhi, Chief Minister Amarinder Singh and Punjab Congress chief Navjot Singh Sidhu in his tweet.

Navjot Sidhu, who continues to take potshots at his Chief Minister, retweeted Harish Rawat, then tweeted, and repeated, that a meeting has been called.

“As per the AICC directive, Congress Legislature Party meeting has been convened at @INCPunjab PPCC Office, Chandigarh on 18 September 2021 (Saturday) 5 PM,” said Mr Sidhu.

Harish Chaudhary and Ajay Maken will be the central observers for the Punjab meeting.

There has been no reaction from Captain Amarinder Singh so far.

Last month, four ministers and around two dozen party legislators had raised a squadron of complaints against the Punjab Chief Minister and said that they had no faith in his ability to honour poll promises.

The Congress has been papering over the differences between the two top leaders in the state unit, telegraphing a message of unity and cooperation.

As recently as September 8, Mr Rawat, speaking to news agency ANI, said that the people assume party leaders in Punjab are fighting because the ”brave” leaders put forward their opinion strongly.

“Punjab is the land of braves. People there put their opinion very strongly there and it looks like they will fight. But, there is nothing like that, and they find solutions to their problems. Punjab Congress is solving their issues themselves. We are not doing anything,” the Congress leader said.

When asked about the relation between Amarinder Singh and Mr Sidhu, Mr Rawat said, “If there would be a dispute, it would be good for Congress.”

The BJP, in a sharp contrast, has replaced four chief ministers in six months. Most recently Vijay Rupani quit as Gujarat Chief Minister a year ahead of polls.. His resignation follows that of BS Yediyurappa in Karnataka in July and a double blow in Uttarakhand, where Tirath Singh Rawat quit barely four months after replacing Trivendra Rawat.

Both Gujarat and Uttarakhand will vote for new governments next year.

Cricketer-turned-politician Navjot Singh Sidhu was declared the Punjab Congress chief in July after weeks of infighting and in face of strong opposition by Captain Amarinder Singh. He has been a vehement critic of the state government.

Even after a month of assuming the new role, Mr Sidhu keeps pulling up the government for not fulfilling the pre-poll promises.

The Congress, which has only a skinny group of states in its kitty, has been battling leadership issues in Punjab, which is quickly turning into a political sinkhole for the grand old party.

The 117-member Punjab assembly will vote early next year.





Source link

Continue Reading

National

Coronavirus Live News Update: India Creates World Record In Vaccinations With 2.5 Crore Doses In A Day – dot newz

Published

on

By


The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390

India crossed 2.5 crore Covid vaccinations in a day for the first time on Friday as the government raced to deliver a record on Prime Minister Narendra Modi’s birthday. Union Health Minister Mansukh Mandaviya tweeted to confirm the “historic” figure.

The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390.

With 34,403 more people testing positive for COVID-19, India’s overall infection tally has increased to 3,33,81,728, while the count of active cases has dipped to 3,39,056, according to Union health ministry data updated on Friday.

The death count due to the disease has climbed to 4,44,248 with 320 more fatalities being recorded, it said.

The number of active cases now comprises 1.03 per cent of the total infections, while the national COVID-19 recovery rate has been recorded at 97.64 per cent, according to the data updated by the ministry.

It said that active COVID-19 cases in the country decreased by 3,867 cases in a span of 24 hours.

Here are the updates on coronavirus (COVID-19) cases:

Over 7 lakh people vaccinated in Assam on PM’s birthday

A total of 7,09,524 people received the COVID-19 vaccine in Assam on Friday as the state government undertook a mega inoculation drive on the occasion of Prime Minister Narendra Modi’s birthday, a bulletin said.

Over 2.16 crore people have been immunised, and 44.02 lakh of them got both doses of the vaccines, it said.

The special drive was conducted in 4,575 COVID Vaccination Centres (CVCs), of which 4,557 were government sites and 18 private ones.



Source link

Continue Reading

National

WHO Emergency Approval For Covaxin Delayed Till October 5 – dot newz

Published

on

By


The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

New Delhi:

World Health Organisation’s (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.

As per WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to granting EUA to Covaxin.

Hanna Nohynek, SAGE member will be introducing session objective setting, an update on regulatory decisions and an overview of Working Group deliverables.

The session will recommend EUA based on the clinical data on Covaxin from phase 1, 2, 3 trial and post-marketing studies on safety, immunogenicity, efficacy and effectiveness.

It will update on global, regional and country-level plans for vaccine safety monitoring.

The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

Meanwhile, Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.

In a series of tweets, Bharat Biotech said that Covaxin clinical trial was fully compiled and available in June 2021.

“#COVAXIN clinical trial data was fully compiled and available in June 2021. All Data was submitted for Emergency Use Listing (EUL) Application to World Health Organization in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback,” Bharat Biotech tweeted.

As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on the approval process and its timelines, it further said.

“We are continuing to work diligently on obtaining WHO EUL at the earliest,” it added.

Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

Covaxin was developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology. Covaxin, which has been developed in collaboration with the Indian Council of Medical Research (ICMR), contains a whole virion inactivated SARS-CoV-2 vaccine, which is produced in Vero cells.

The vaccine is stable at 2 degrees Celsius to 8 degrees Celsius (refrigerated) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)





Source link

Continue Reading

Trending

Copyright © 2017 Dot Newz | Developed by MCVP Group 8